Cerebral cortex dose sparing for glioblastoma patients: IMRT versus robust treatment planning

Cerebral cortex dose sparing for glioblastoma patients: IMRT versus robust treatment planning

Abstract Background To date, patients with glioblastoma still have a bad median overall survival rate despite radiation dose-escalation and combined modality treatment. Neurocognitive decline is a crucial adverse event which may be linked to high doses to the cortex. In a planning study, we investig...

Full description

Bibliographic Details
Main Authors: Ann-Katrin Exeli, Daniel Kellner, Lukas Exeli, Phil Steininger, Frank Wolf, Felix Sedlmayer, Heinz Deutschmann
Format: Article
Language:English
Published: BMC 2018-02-01
Series:Radiation Oncology
Subjects:
Radiotherapy
Robust treatment planning
IMRT
Glioblastoma
Cortex
Cortical sparing
Online Access:http://link.springer.com/article/10.1186/s13014-018-0953-x

Internet

http://link.springer.com/article/10.1186/s13014-018-0953-x

Similar Items